RAGHX vs. FBTCX
Compare and contrast key facts about Virtus Health Sciences Fund (RAGHX) and Fidelity Advisor Biotechnology Fund Class C (FBTCX).
RAGHX is managed by Allianz. It was launched on Feb 4, 2002. FBTCX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
RAGHX vs. FBTCX - Performance Comparison
Loading graphics...
RAGHX vs. FBTCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RAGHX Virtus Health Sciences Fund | -9.13% | 7.23% | -2.33% | 2.57% | -11.64% | 25.44% | 13.76% | 26.69% | 4.37% | 17.33% |
FBTCX Fidelity Advisor Biotechnology Fund Class C | 2.09% | 38.48% | -2.00% | 9.86% | -8.64% | -3.72% | 31.17% | 24.82% | -4.55% | 24.81% |
Returns By Period
In the year-to-date period, RAGHX achieves a -9.13% return, which is significantly lower than FBTCX's 2.09% return. Over the past 10 years, RAGHX has underperformed FBTCX with an annualized return of 6.97%, while FBTCX has yielded a comparatively higher 10.32% annualized return.
RAGHX
- 1D
- 2.24%
- 1M
- -8.95%
- YTD
- -9.13%
- 6M
- -0.59%
- 1Y
- 0.22%
- 3Y*
- -0.85%
- 5Y*
- 0.92%
- 10Y*
- 6.97%
FBTCX
- 1D
- 5.09%
- 1M
- -0.81%
- YTD
- 2.09%
- 6M
- 15.10%
- 1Y
- 54.26%
- 3Y*
- 17.00%
- 5Y*
- 6.73%
- 10Y*
- 10.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
RAGHX vs. FBTCX - Expense Ratio Comparison
RAGHX has a 1.37% expense ratio, which is lower than FBTCX's 1.75% expense ratio.
Return for Risk
RAGHX vs. FBTCX — Risk / Return Rank
RAGHX
FBTCX
RAGHX vs. FBTCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus Health Sciences Fund (RAGHX) and Fidelity Advisor Biotechnology Fund Class C (FBTCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RAGHX | FBTCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.06 | 1.90 | -1.96 |
Sortino ratioReturn per unit of downside risk | 0.05 | 2.49 | -2.44 |
Omega ratioGain probability vs. loss probability | 1.01 | 1.32 | -0.31 |
Calmar ratioReturn relative to maximum drawdown | -0.04 | 3.08 | -3.12 |
Martin ratioReturn relative to average drawdown | -0.12 | 12.19 | -12.32 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| RAGHX | FBTCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.06 | 1.90 | -1.96 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.06 | 0.29 | -0.23 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.40 | 0.42 | -0.02 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.48 | 0.27 | +0.21 |
Correlation
The correlation between RAGHX and FBTCX is 0.80, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
RAGHX vs. FBTCX - Dividend Comparison
RAGHX has not paid dividends to shareholders, while FBTCX's dividend yield for the trailing twelve months is around 1.65%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RAGHX Virtus Health Sciences Fund | 0.00% | 0.00% | 0.00% | 0.00% | 9.51% | 21.85% | 14.50% | 6.89% | 16.12% | 0.00% | 0.00% | 23.19% |
FBTCX Fidelity Advisor Biotechnology Fund Class C | 1.65% | 1.68% | 0.00% | 0.00% | 0.00% | 24.50% | 9.78% | 7.92% | 2.92% | 0.00% | 0.00% | 5.73% |
Drawdowns
RAGHX vs. FBTCX - Drawdown Comparison
The maximum RAGHX drawdown since its inception was -40.23%, smaller than the maximum FBTCX drawdown of -64.04%. Use the drawdown chart below to compare losses from any high point for RAGHX and FBTCX.
Loading graphics...
Drawdown Indicators
| RAGHX | FBTCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.23% | -64.04% | +23.81% |
Max Drawdown (1Y)Largest decline over 1 year | -14.48% | -13.63% | -0.85% |
Max Drawdown (5Y)Largest decline over 5 years | -22.14% | -37.26% | +15.12% |
Max Drawdown (10Y)Largest decline over 10 years | -28.01% | -39.37% | +11.36% |
Current DrawdownCurrent decline from peak | -14.25% | -2.75% | -11.50% |
Average DrawdownAverage peak-to-trough decline | -7.06% | -23.21% | +16.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.79% | 3.75% | +1.04% |
Volatility
RAGHX vs. FBTCX - Volatility Comparison
The current volatility for Virtus Health Sciences Fund (RAGHX) is 5.66%, while Fidelity Advisor Biotechnology Fund Class C (FBTCX) has a volatility of 9.37%. This indicates that RAGHX experiences smaller price fluctuations and is considered to be less risky than FBTCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| RAGHX | FBTCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.66% | 9.37% | -3.71% |
Volatility (6M)Calculated over the trailing 6-month period | 11.56% | 17.02% | -5.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.45% | 25.99% | -6.54% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.40% | 23.48% | -7.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.46% | 24.66% | -7.20% |